EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti‐Apoptotic and Neurite‐Protective Nanomedicine Augments Embryonic Stem Cells‐Derived Retinal Ganglion Cell Transplantation in Glaucoma Recovery

Moxin Chen, Xiaoyan Jiang, Yuanhui Wang, Zhaobin Luo, Yu Zhang, Siwei Liu, Rui Huang, Dandan Zhang, Zhimin Tang, Yahan Ju, Shaohui Pan, Ni Ni und 3 weitere

Advanced Science · 2026

DOI: 10.1002/advs.202513499 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Moxin Chen und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China. Hauptthemen laut MEDLINE: Retinal Ganglion Cells, Glaucoma, Apoptosis, Nanomedicine. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Key Science and Technology Research and Development Projects of Jiangxi Province, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Retinal ganglion cell (RGC) degeneration represents a cardinal etiology of irreversible vision loss in glaucoma, where efficacious regenerative therapies remain scarce. RGC replacement therapy holds promise for visual function restoration, yet its therapeutic efficacy is constrained by the hostile glaucomatous microenvironment, dominated by oxidative stress that compromises transplanted RGC survival. Here, we report the design of multifunctional lithium‐epigallocatechin gallate nanoparticles (Li‐EGCG NPs) to synergistically enhance antioxidant capacity and neuroprotection. These NPs exhibit uniform spherical morphology, broad‐spectrum reactive oxygen species scavenging activity, and exceptional biocompatibility with embryonic stem cell‐derived RGCs (ESC‐RGCs). In vitro, Li‐EGCG NPs mitigate oxidative stress‐induced apoptosis, preserve neurite integrity, and maintain mitochondrial homeostasis in ESC‐RGCs. Transcriptomic analyses reveal activation of neuroprotective pathways, including apoptosis regulation, axon guidance, and mitochondrial function. In a retinal ischemia/reperfusion injury model, which serves as an acute pathological glaucomatous injury model, combinatorial Li‐EGCG NPs and ESC‐RGCs transplantation markedly improves ESC‐RGCs survival, preserves retinal architecture, and restores visual function beyond single‐modality therapy. This study establishes Li‐EGCG NPs as a robust nanomedicine platform for retinal neurodegenerative diseases, offering a promising strategy to augment cell‐based therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal Ganglion CellsGlaucomaApoptosisNanomedicineEmbryonic Stem CellsNeuritesCatechinAnimalsMiceNeuroprotective AgentsOxidative StressNanoparticles

Stichwörter der Autor:innen

antioxidative nanomedicineembryonic stem cellsglaucomametal‐polyphenol nanoparticleretinal ganglion cells

Substanzen

Neuroprotective AgentsCatechinepigallocatechin gallate

Autor:innen und Institutionen

  • Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, P. R. China.
  • Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, P. R. China.
  • Materdicine Lab, School of Life Sciences, Shanghai University, Shanghai, P. R. China.
  • School of Medicine, Shanghai University, Shanghai, China.
  • State Key Laboratory of Eye Health, Eye Hospital, Wenzhou Medical University, Wenzhou, P. R. China.

ORCID-Profile: Yu Chen

Förderung

  • National Key R&D Program of China
  • Key Science and Technology Research and Development Projects of Jiangxi Province
  • National Key Research and Development Program of China

Zitieren

APA

Chen, M., Jiang, X., Wang, Y., Luo, Z., Zhang, Y., Liu, S., Huang, R., Zhang, D., Tang, Z., Ju, Y., Pan, S., Ni, N., Feng, W., Chen, Y., & Gu, P. (2026). Anti‐Apoptotic and Neurite‐Protective Nanomedicine Augments Embryonic Stem Cells‐Derived Retinal Ganglion Cell Transplantation in Glaucoma Recovery. Advanced Science. https://doi.org/10.1002/advs.202513499

Vancouver

Chen M, Jiang X, Wang Y, Luo Z, Zhang Y, Liu S, et al. Anti‐Apoptotic and Neurite‐Protective Nanomedicine Augments Embryonic Stem Cells‐Derived Retinal Ganglion Cell Transplantation in Glaucoma Recovery. Advanced Science. 2026. doi:10.1002/advs.202513499

BibTeX
@article{Chen2026,
  author = {Chen, Moxin and Jiang, Xiaoyan and Wang, Yuanhui and Luo, Zhaobin and Zhang, Yu and Liu, Siwei and Huang, Rui and Zhang, Dandan and Tang, Zhimin and Ju, Yahan and Pan, Shaohui and Ni, Ni and Feng, Wei and Chen, Yu and Gu, Ping},
  title = {Anti‐Apoptotic and Neurite‐Protective Nanomedicine Augments Embryonic Stem Cells‐Derived Retinal Ganglion Cell Transplantation in Glaucoma Recovery},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202513499}
}
Kostenlos starten →